HomeInsightsPB

Sandu Pharmaceuticals Ltd PB Ratio

Sandu Pharmaceuticals Ltd PB Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

1.0 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Sandu Pharmaceuticals Ltd

NSE: SANDUPHARMA

PB

1.4

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Sandu Pharmaceuticals Ltd is 1.4 as of 07 Nov 24.
  • The P/B Ratio of Sandu Pharmaceuticals Ltd changed from 1.3 on March 2023 to 1.4 on March 2024 . This represents a CAGR of 3.77% over 2 years. .

Historical P/B Ratio of Sandu Pharmaceuticals Ltd

No data available

Company Fundamentals for Sandu Pharmaceuticals Ltd

Market Cap

55 Cr

EPS

1.6

P/E Ratio (TTM) *

36.8

P/B Ratio (TTM) *

1.4

Day’s High *

57.87

Day’s Low

56.7

DTE *

0.0

ROE *

3.6

52 Week High

85.0

52 Week Low

54.0

ROCE *

5.3

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Sandu Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 202457.85
06 Nov 202458.05
05 Nov 202457.05
04 Nov 202455.69
01 Nov 202456.33
31 Oct 202455.41
30 Oct 202455.22
29 Oct 202454.62
28 Oct 202454.68
25 Oct 202454.98

BlinkX Score for Sandu Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sandu Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Sandu Pharmaceuticals Ltd155
Sun Pharmaceuticals Industries Ltd984,29,841
Divis Laboratories Ltd5071,58,179
Cipla Ltd3611,27,063
Mankind Pharma Ltd2631,09,234
Dr Reddys Laboratories Ltd3151,07,398

Key Valuation Metric of Sandu Pharmaceuticals Ltd

Share Price

₹58

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Sandu Pharmaceuticals Ltd News Hub

News

Sandu Pharmaceuticals declare Quarterly Result

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 N...

Read more

05 Nov 202413:43

News

Board of Sandu Pharmaceuticals recommends final dividend

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

13 Aug 202409:53

News

Sandu Pharmaceuticals AGM scheduled

Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company ...

Read more

13 Aug 202409:53

News

Sandu Pharmaceuticals schedules board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 A...

Read more

06 Aug 202414:29

News

Sandu Pharmaceuticals to discuss results

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 Ju...

Read more

01 Jun 202409:25

News

Sandu Pharmaceuticals to hold board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 M...

Read more

22 May 202412:40

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Sandu Pharmaceuticals Ltd

What is the PB ratio of Sandu Pharmaceuticals Ltd?

The current PB ratio of Sandu Pharmaceuticals Ltd is 1.38. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Sandu Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Sandu Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Sandu Pharmaceuticals Ltd calculated?

The PB ratio of Sandu Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Sandu Pharmaceuticals Ltd?

A high PB ratio suggests that Sandu Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Sandu Pharmaceuticals Ltd?

A low PB ratio of Sandu Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Sandu Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Sandu Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*